PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för chidamide. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

20 hits

Bibliografisk träff 2024-07-18

Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemia.

Liu E, Chen Y, Qin M, Yue K, Sun S, Jiang Y, Li X.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2024.116663

Bibliografisk träff 2024-04-05

Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.

Velma GR, Krider IS, Alves ETM, Courey JM, Laham MS, Thatcher GRJ.

J Med Chem · research support, non-u.s. gov't; review-article; review; journal article; research support, n.i.h., extramural · DOI 10.1021/acs.jmedchem.3c02112

Bibliografisk träff 2024-03-14

Discovery of novel itaconimide-based derivatives as potent HDAC inhibitors for the efficient treatment of prostate cancer.

Jiang Q, Tang Y, Hu Q, Wang B, Ruan X, Zhou Q.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2024.116315

Bibliografisk träff 2023-08-28

Rational discovery of dual FLT3/HDAC inhibitors as a potential AML therapy.

Wang Z, Wu D, Zhao X, Liu C, Jia S, He Q, Huang F, Cheng Z, Lu T, Chen Y, Chen Y, Yang P, Lu S.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2023.115759

Bibliografisk träff 2023-06-25

Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?

Amin SA, Khatun S, Gayen S, Das S, Jha T.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2023.115594

Bibliografisk träff 2023-05-15

Discovery of (S)-N-(2-Amino-4-fluorophenyl)-4-(1-(3-(4-((dimethylamino)methyl)phenyl)-6-oxopyridazin-1(6H)-yl)ethyl)benzamide as Potent Class I Selective HDAC Inhibitor for Oral Anticancer Drug Candidate.

Li D, Zhang Z, Li Y, Wang X, Zhong H, Yang H, Xi Y, Liu H, Shen A, Hu Y.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.3c00525

Bibliografisk träff 2023-03-19

Design and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response.

Sun N, Yang K, Yan W, Yao M, Yu C, Duan W, Gu X, Guo D, Jiang H, Xie C, Cheng J.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.2c01985

Bibliografisk träff 2023-01-21

Discovery of novel and bioavailable histone deacetylases and cyclin-dependent kinases dual inhibitor to impair the stemness of leukemia cells.

Liu Y, Wei Y, Wang X, Ma L, Li X, Sun Y, Wu Y, Zhang L, Wang J, Li M, Zhang K, Wei M, Yang G, Yang C.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2023.115140

Bibliografisk träff 2022-11-13

Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment.

Yang FF, Hu T, Liu JQ, Yu XQ, Ma LY.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2022.114920

Bibliografisk träff 2022-05-27

Design and synthesis of highly TRAIL expression HDAC inhibitors based on ONC201 to promote apoptosis of colorectal cancer.

Cui H, Hu Z, Yang K, Huang J, Wu Y, Chen Q, Wei R, Wang P, Wang H, Li H, Chen Y, Lu T, Yao Y, Zhu Y.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2022.114484

Bibliografisk träff 2022-01-05

Targeted Discovery of Amantamide B, an Ion Channel Modulating Nonapeptide from a South China Sea Oscillatoria Cyanobacterium.

Li T, Xi C, Yu Y, Wang N, Wang X, Iwasaki A, Fang F, Ding L, Li S, Zhang W, Yuan Y, Wang T, Yan X, He S, Cao Z, Naman CB.

J Nat Prod · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jnatprod.1c00983

Bibliografisk träff 2021-12-30

Design and synthesis of dual inhibitors targeting snail and histone deacetylase for the treatment of solid tumour cancer.

Cui H, Huang J, Lei Y, Chen Q, Hu Z, Niu J, Wei R, Yang K, Li H, Lu T, Zhu Y, Huang Y.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2021.114082

Bibliografisk träff 2021-12-18

Design and synthesis of HDAC inhibitors to enhance the therapeutic effect of diffuse large B-cell lymphoma by improving metabolic stability and pharmacokinetic characteristics.

Cui H, Hong Q, Wei R, Li H, Wan C, Chen X, Zhao S, Bu H, Zhang B, Yang D, Lu T, Chen Y, Zhu Y.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2021.114049

Bibliografisk träff 2020-10-08

Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.

Bass AKA, El-Zoghbi MS, Nageeb EM, Mohamed MFA, Badr M, Abuo-Rahma GEA.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2020.112904

Bibliografisk träff 2020-07-16

Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.

Ho TCS, Chan AHY, Ganesan A.

J Med Chem · review; journal article · DOI 10.1021/acs.jmedchem.0c00830

Bibliografisk träff 2019-12-13

Nicotinamide Phosphoribosyltransferase (NAMPT) Is a New Target of Antitumor Agent Chidamide.

Wu Y, Wang L, Huang Y, Chen S, Wu S, Dong G, Sheng C.

ACS Med Chem Lett · rapid-communication; journal article · DOI 10.1021/acsmedchemlett.9b00407

Bibliografisk träff 2019-04-30

A new lateral root growth inhibitor from the sponge-derived fungus Aspergillus sp. LS45.

Huang L, Ding L, Li X, Wang N, Yan Y, Yang M, Cui W, Benjamin Naman C, Cheng K, Zhang W, Zhang B, Jin H, He S.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2019.04.051

Bibliografisk träff 2019-04-29

Discovery of novel phenoxybenzamide analogues as Raf/HDAC dual inhibitors.

Geng A, Cui H, Zhang L, Chen X, Li H, Lu T, Zhu Y.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2019.04.047

Bibliografisk träff 2019-02-14

Design, synthesis and biological evaluation of novel isoindolinone derivatives as potent histone deacetylase inhibitors.

Chen X, Zhao S, Li H, Wang X, Geng A, Cui H, Lu T, Chen Y, Zhu Y.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2019.02.032

Bibliografisk träff 2017-07-18

Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives.

Lu D, Yan J, Wang L, Liu H, Zeng L, Zhang M, Duan W, Ji Y, Cao J, Geng M, Shen A, Hu Y.

ACS Med Chem Lett · rapid-communication; journal article · DOI 10.1021/acsmedchemlett.7b00172

Go to research.

Publications in the selection

Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemia.

Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.

Discovery of novel itaconimide-based derivatives as potent HDAC inhibitors for the efficient treatment of prostate cancer.

Rational discovery of dual FLT3/HDAC inhibitors as a potential AML therapy.

Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?

Discovery of (<i>S</i>)-<i>N</i>-(2-Amino-4-fluorophenyl)-4-(1-(3-(4-((dimethylamino)methyl)phenyl)-6-oxopyridazin-1(6<i>H</i>)-yl)ethyl)benzamide as Potent Class I Selective HDAC Inhibitor for Oral Anticancer Drug Candidate.

Design and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response.

Discovery of novel and bioavailable histone deacetylases and cyclin-dependent kinases dual inhibitor to impair the stemness of leukemia cells.

Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment.

Design and synthesis of highly TRAIL expression HDAC inhibitors based on ONC201 to promote apoptosis of colorectal cancer.

Targeted Discovery of Amantamide B, an Ion Channel Modulating Nonapeptide from a South China Sea <i>Oscillatoria</i> Cyanobacterium.

Design and synthesis of dual inhibitors targeting snail and histone deacetylase for the treatment of solid tumour cancer.

Design and synthesis of HDAC inhibitors to enhance the therapeutic effect of diffuse large B-cell lymphoma by improving metabolic stability and pharmacokinetic characteristics.

Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.

Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight.

Nicotinamide Phosphoribosyltransferase (NAMPT) Is a New Target of Antitumor Agent Chidamide.

A new lateral root growth inhibitor from the sponge-derived fungus Aspergillus sp. LS45.

Discovery of novel phenoxybenzamide analogues as Raf/HDAC dual inhibitors.

Design, synthesis and biological evaluation of novel isoindolinone derivatives as potent histone deacetylase inhibitors.

Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives.